One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Artificial intelligence-driven categorization of rheumatological disease subgroups
doi : 10.1093/rheumatology/keaf273
Volume 64, Issue 9, September 2025
Measuring what matters! The role of AAV-PRO in patient-centered care for EGPA: insights from the study by Delvino et al. Free
A fresh look at immunocytometry’s role in personalized rheumatology Open Access
Post-traumatic stress disorder and systemic lupus erythematosus: insights from a systematic review
Psoriatic arthritis flare incidence, definition and risk factors: a systematic review
Patient Reported Outcome Measures for Rheumatoid Arthritis Disease Activity: Rasch measurement theory to identify items and domains Open Access
What is the economic burden of delayed axial spondyloarthritis diagnosis in the UK? Open Access
Indications, efficacy and safety of rituximab in childhood-onset systemic lupus erythematosus: a retrospective study of the JIR cohort
Consensus nomenclature and abbreviation for anti-synthetase syndrome: an IMACS project
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study Open Access
Long-term effectiveness and safety of baricitinib treatment on refractory or severe juvenile dermatomyositis
Trends in remission rates for rheumatoid arthritis in England and Wales: a population-level cohort study Open Access
Endothelial cell dysfunction in RA: biomarkers IL-8, E-selectin, VCAM-1 and MCP-1 correlated with PET/CT
Differential impact of immune-mediated inflammatory diseases before versus after cancer on patient survival: a nationwide cohort study
Epidemiology of major and minor relapses in giant cell arteritis according to EULAR definitions: insights from the ARTESER registry
The incidence of anti-HMGCR immune-mediated necrotizing myopathy: an Australian and UK retrospective multi-site cohort study Open Access
The complex diagnosis of primary heart involvement in systemic sclerosis: red flags to drive the choice of cardiac magnetic resonance
Impact of glucocorticoid tapering speed on renal outcomes in proliferative lupus nephritis: a multicentre retrospective study
Transition of clinical remission rates with molecular targeted therapies in rheumatoid arthritis in Japan: insights from the FIRST registry
Effect of rituximab on long-term damage acquisition in patients with systemic lupus erythematosus Open Access
Single-cell transcriptome analysis profiles cellular and molecular alterations in aortic tissue from patients with Behçet’s syndrome
Axial psoriatic arthritis in patients not fulfilling the back pain entry features of the ASAS Classification Criteria for Axial Spondyloarthritis: findings from the ATTRACT Study
Association of clinical and sonographic factors with discrepancy between patients’ and evaluators’ global assessments in psoriatic arthritis
The Fibrosis-4 Index (FIB-4) correlates with cardiovascular risk and insulin resistance in patients with rheumatoid arthritis
Exploring the impact of conventional and targeted DMARDs on body weight in patients with PsA
Continuous decline in Paget’s disease of bone: a One Health perspective on 2342 new diagnoses and their association with rural livestock
The lack of association between cumulative MTX dose and liver fibrosis in PsA: a cohort study
Anti-mitochondrial antibodies as markers of disease activity in childhood-onset systemic lupus erythematosus: a longitudinal cohort study
A novel approach to refractory idiopathic inflammatory myopathy: CD19 CAR T-cell therapy—case report and literature review
Step-down treatment with mepolizumab for eosinophilic granulomatosis with polyangiitis: a real-life single-centre study
Type I interferon dysregulation drives distinct pathogenic pathways in early- and late-onset lupus nephritis
Secukinumab is effective and safe for patients with giant cell arteritis after tocilizumab failure
Efficacy and safety of ultrasound-guided needle muscle biopsy in the diagnosis of idiopathic inflammatory myopathies
Targeting interferon responses in juvenile dermatomyositis: Siglec-1 as an in vitro biomarker for JAK inhibitor efficacy Open Access
Functional brain networks related to processing speed and memory in SLE: a connectome-based modelling study
Impact of immune checkpoint TIGIT on the activation and function of natural killer cells in rheumatoid arthritis patients
Characterization of fibroblast-like synoviocytes from the synovial fluid of patients affected by juvenile idiopathic arthritis Open Access
M694I variant of MEFV drives pathogenesis of familial Mediterranean fever through enhanced Th17 cell differentiation
Retraction of: Altered CD4+ T cell and cytokine levels in peripheral blood and skin samples from systemic sclerosis patients and IL-35 in CD4+ T cell growth Free
Evaluating the relevance of the 2024 BSR systemic sclerosis guideline for juvenile systemic sclerosis
Switching to IL-6 inhibitors or abatacept in elderly patients with rheumatoid arthritis achieving low disease activity with JAK inhibitors: a pilot study
Leg edema in systemic sclerosis: uncovering fasciitis and myositis as key underlying causes
Upadacitinib in the treatment of Takayasu arteritis: a case report on new perspectives on targeted immunomodulation
Recapitulation of clinical features in a patient-derived xenograft mouse model of VEXAS syndrome
Intensive therapeutic plasma exchange in life-threatening ANCA-associated vasculitis
Comment on: Gout incidence in metformin versus sodium–glucose co-transporter-2 inhibitor users: a retrospective cohort study
Comment on: Gout incidence in metformin versus sodium–glucose co-transporter-2 inhibitor users: a retrospective cohort study: Reply
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome: a hidden culprit behind joint limitation
Novel location of IgG4-related disease in the anterior mediastinum
